ChengDa Pharmaceuticals Co. Ltd. (301201) — Cash Flow Reinvestment Rate
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Cash Flow Reinvestment Rate of 42.29x as of December 2024, reinvesting CN¥1.21 Billion (capex CN¥286.36 Million plus investments CN¥-925.26 Million) from operating cash flow of CN¥28.65 Million. Explore how much does ChengDa Pharmaceuticals Co. Ltd. reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ChengDa Pharmaceuticals Co. Ltd. Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for ChengDa Pharmaceuticals Co. Ltd. across 6 annual periods. Also explore ChengDa Pharmaceuticals Co. Ltd. (301201) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for ChengDa Pharmaceuticals Co. Ltd. (2019–2024)
Year-by-year capital reinvestment analysis for ChengDa Pharmaceuticals Co. Ltd.. For live market cap and broader valuation context, see market cap of ChengDa Pharmaceuticals Co. Ltd..
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 42.29x | CN¥1.21 Billion | CN¥28.65 Million | CN¥286.36 Million | ▲ +678.6% |
| 2023 | 5.43x | CN¥1.04 Billion | CN¥192.07 Million | CN¥224.67 Million | ▼ -78.3% |
| 2022 | 25.06x | CN¥1.19 Billion | CN¥47.67 Million | CN¥205.69 Million | ▲ +651.3% |
| 2021 | 3.34x | CN¥277.28 Million | CN¥83.14 Million | CN¥138.70 Million | ▲ +481.4% |
| 2020 | 0.57x | CN¥73.99 Million | CN¥128.97 Million | CN¥63.81 Million | ▼ -60.8% |
| 2019 | 1.46x | CN¥98.73 Million | CN¥67.52 Million | CN¥51.06 Million | — |